Updates from SABCS 2023 – HER2+ Breast Cancer

Icon Objectives

Learning Objectives

  1. Summarize the most significant treatment advances in HER2+ Breast Cancer presented at SABCS 2023
  2. Describe key data presented at SABCS 2023 and the impact on Canadian practices
  3. To discuss current unmet needs in the management of HER2+ Breast Cancer
Icon Panelists


Dr. David Cescon

Icon Panelists


Dr. Jean-Pierre Ayoub

This program has been made possible through unrestricted support from Seagen